YTHDF2 and acute myeloid leukemia: In detail, YTHDF2 promotes the development and propagation of AML CSCs by degrading multiple m6A-modified mRNAs such as TNF receptor superfamily member 1b (TNFRSF1b) that are associated with the functional integrity of AML CSCs.